Searching journal content for insulin-like growth factor receptor (as phrase) in full text.

Displaying results 1-10 of 113

For checked items

view abstracts
download to citation manager

Select this article
Review:
- Anna Angelousi,
- Georgios K Dimitriadis,
- Georgios Zografos,
- Svenja Nölting,
- Gregory Kaltsas,
- and Ashley Grossman
Molecular targeted therapies in adrenal, pituitary and parathyroid malignancies Endocr Relat Cancer 24 (6) R239-R259, doi:10.1530/ERC-16-0542 first published on 11 April 2017
...insulin-like growth factor receptor 1 (IGF1R) antibody cixutumumab and mitotane as a first-line therapy for patients with recurrent/ metastatic adrenocortical carcinoma: a multi-institutional NCI-sponsored trial. Hormones and Cancer 5 232–239. (doi:10.1007/ s12672-014-0182-1) Libè R, Groussin L, Tis ~~~
Select this article
Review:
- Christopher W Rowe,
- Jonathan W Paul,
- Craig Gedye,
- Jorge M Tolosa,
- Cino Bendinelli,
- Shaun McGrath,
- and Roger Smith
Targeting the TSH receptor in thyroid cancer Endocr Relat Cancer 24 (6) R191-R202, doi:10.1530/ERC-17-0010 first published on 28 March 2017
...insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid. Journal of Clinical Endocrinology and Metabolism 96 766–774. (doi:10.1210/jc.2010-1255) Matsumoto H, Sakamoto A, Fujiwara M, Yano Y, Shishido-Hara Y, Fujioka Y & Kamma H 2008 Dec ~~~
Select this article
Thematic Review:
- Patricia V Elizalde,
- Rosalía I Cordo Russo,
- Maria F Chervo,
- and Roxana Schillaci
ErbB-2 nuclear function in breast cancer growth, metastasis and resistance to therapy Endocr Relat Cancer 23 (12) T243-T257, doi:10.1530/ERC-16-0360 first published on 7 October 2016
..., such as expression of constitutively active truncated forms of ErbB-2, presence of ligand-induced ErbB-2/ErbB-3 dimers and ErbB-2/ insulin-like growth factor receptor I (IGF1-R) dimerization (reviewed in Esteva et al. 2010). Hyperactivation of the PI3K/AKT pathway is the best acknowledged alteration in downstream ~~~
Select this article
Review:
- Aleksandra M Ochnik and
- Robert C Baxter
Combination therapy approaches to target insulin-like growth factor receptor signaling in breast cancer Endocr Relat Cancer 23 (11) R527-R550, doi:10.1530/ERC-16-0218
...DOI: 10.1530/ERC-16-0218 http://.endocrinology-journals.org 2016 Society for Endocrinology Printed in Great Britain Published by Bioscientifica Ltd. Abstract Insulin-like growth factor receptor (IGF1R) signaling as a therapeutic target has been widely studied and clinically tested. Despite ~~~
Select this article
Research:
- Zara Zelenko,
- Emily Jane Gallagher,
- Irini Markella Antoniou,
- Deepali Sachdev,
- Anupma Nayak,
- Douglas Yee,
- and Derek LeRoith
EMT reversal in human cancer cells after IR knockdown in hyperinsulinemic mice Endocr Relat Cancer 23 (9) 747-758, doi:10.1530/ERC-16-0142 first published on 19 July 2016
...DA, GrabinerBC, LinX, LewisMT, GottardisMM, WongTW, AttarRM, etal. 2007 Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF ~~~
Select this article
Review:
- Conleth G Murphy and
- Maura N Dickler
Endocrine resistance in hormone-responsive breast cancer: mechanisms and therapeutic strategies Endocr Relat Cancer 23 (8) R337-R352, doi:10.1530/ERC-16-0121 first published on 12 July 2016
...are evaluating additional FGFR targeting agents AZD4547, lucitanib, BGJ398, and JNJ42756493 in breast cancer (https://www.clinicaltrials.gov/ ct2/results?term=%22FGFR%22+AND+%22breast+cance r%22&recr=Open, accessed online 28 February 2016). Inhibition of insulin-like growth factor receptor 1 (IGFR1 ~~~
Select this article
Research:
- Régia Caroline Peixoto Lira,
- Paola Fernanda Fedatto,
- David Santos Marco Antonio,
- Letícia Ferro Leal,
- Carlos Eduardo Martinelli,
- Margaret de Castro,
- Silvio Tucci,
- Luciano Neder,
- Leandra Ramalho,
- Ana Luiza Seidinger,
- Izilda Cardinalli,
- Maria José Mastellaro,
- José Andres Yunes,
- Silvia Regina Brandalise,
- Luiz Gonzaga Tone,
- Sonir Roberto Rauber Antonini,
- and Carlos Alberto Scrideli
IGF2 and IGF1R in pediatric adrenocortical tumors: roles in metastasis and steroidogenesis Endocr Relat Cancer 23 (6) 481-493, doi:10.1530/ERC-15-0426 first published on 16 May 2016
...therapy. Indian Journal of Medical and Paediatric Oncology 31 132136. (doi:10.4103/0971-5851.76197) AleksicT, ChitnisMM, PerestenkoOV, GaoS, ThomasPH, TurnerGD, ProtheroeAS, HowarthM & MacaulayVM 2010 Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cells ~~~
Select this article
Research:
- Lena Lapkina-Gendler,
- Itai Rotem,
- Metsada Pasmanik-Chor,
- David Gurwitz,
- Rive Sarfstein,
- Zvi Laron,
- and Haim Werner
Identification of signaling pathways associated with cancer protection in Laron syndrome Endocr Relat Cancer 23 (5) 399-410, doi:10.1530/ERC-16-0054 first published on 18 April 2016
....2009.05.023) PollakM 2008 Insulin and insulin-like growth factor signalling in neoplasia. Nature Reviews Cancer 8 915928. (doi:10.1038/nrc2536) PollakM 2012 The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nature Reviews Cancer 12 159169. RenehanAG, Zwahlen ~~~
Select this article
Research:
- Yunhui Cheng,
- Raili Emilia Kerppola,
- and Tom Klaus Kerppola
ATR-101 disrupts mitochondrial functions in adrenocortical carcinoma cells and in vivo Endocr Relat Cancer 23 (4) 1-19, doi:10.1530/ERC-15-0527 first published on 3 February 2016
...insulin-like growth factor receptor in adrenocortical carcinoma. Journal of Clinical Endocrinology & Metabolism 94 204–212. (doi:10.1210/jc.20081456) Bergenstal DH, Lipsett M, Moy RH & Hertz R 1959 Regression of adrenal cancer and suppression of adrenal function in man by o, p’ DDD. Transactions of ~~~
Select this article
Research:
- Larissa Akemi Kido,
- Fabio Montico,
- Rafael Sauce,
- Aline Barbosa Macedo,
- Elaine Minatel,
- Débora Barbosa Vendramini Costa,
- João Ernesto de Carvalho,
- Ronaldo Aloise Pilli,
- and Valeria Helena Alves Cagnon
Anti-inflammatory therapies in TRAMP mice: delay in PCa progression Endocr Relat Cancer 23 (4) 235-250, doi:10.1530/ERC-15-0540 first published on 15 January 2016
...adenocarcinoma (P<0.05), in contrast to the T12 control group with 25% and 9.5%, respectively Figure 7 Western blotting analysis of cyclooxygenase-2 (COX2), phosphorylated signal transducer and activator of transcription 3 (pSTAT3), factor nuclear kappaB (NFB), insulin-like growth factor receptor 1 (IGFR1 ~~~

For checked items

view abstracts
download to citation manager

Endocrine-Related Cancer

Searching journal content for insulin-like growth factor receptor (as phrase) in full text.

Search Results

Modify Results

This search

New Articles: issue in progress

Most

Viewed

Cited

Citation format:
Results / page:
Results order: